Parameter | Before intervention* (Surveillance phase 1) | During intervention** (Surveillance phase 2) |
---|---|---|
Patients (n) | 1,640 | 1,924 |
Patient days (n) | 25,427 | 28,527 |
Median length of stay (days) | 15.50 | 14.83 |
UTC days (n) | 4,861 | 4,347 |
UTC use (per 100 patient days) | 19.12 | 15.24 |
Rate ratio UTC use (95%CI) p-value (compared to before intervention) | 1 = reference | 0.80 (0.77–0.83) p < 0.0001 |
CAUTI (n) | 34 | 27 |
Incidence CAUTI per 100 patients | 2.07 | 1.40 |
Incidence ratio CAUTI (95%CI) p-value (compared to before intervention) | 1 = reference | 0.68 (0.41–1.12) p = 0.1279 |
Incidence density CAUTI per 1000 patient days | 1.34 | 0.95 |
Incidence density ratio CAUTI per 1000 patient days (95%CI) p-value (compared to before intervention) | 1 = reference | 0.71 (0.42–1.17)p = 0.1816 |
Incidence density CAUTI per 1000 UTC days | 6.99 | 6.21 |
Incidence density ratio CAUTI per 1000 UTC days (95%CI) p-value (compared to before intervention) | 1 = reference | 0.89 (0.53–1.47) p = 0.6492 |